EUVIMEDEUVIMED entdecken
Crossref

CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability

A. Matvere

European Journal of Cancer · 2026-11 · 248 · 118158

DOI: 10.1016/j.ejca.2026.118158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von A. Matvere.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Matvere, A. (2026). CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability. European Journal of Cancer, 248, 118158. https://doi.org/10.1016/j.ejca.2026.118158

Vancouver

Matvere A. CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability. European Journal of Cancer. 2026;248:118158. doi:10.1016/j.ejca.2026.118158

BibTeX
@article{Matvere2026,
  author = {Matvere, A.},
  title = {CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {118158},
  doi = {10.1016/j.ejca.2026.118158}
}
Kostenlos starten →